Can semaglutide be used to treat alcohol use disorder? episode artwork

EPISODE · May 2, 2026 · 31 MIN

Can semaglutide be used to treat alcohol use disorder?

from The Lancet in conversation with · host The Lancet Group

The Lancet’s Niall Boyce and Jonathan Pimm, and eBioMedicine’s Kalypso Karastergiou discuss an exciting new potential treatment for alcohol use disorder: semaglutide. As new research is published in The Lancet, they go behind the headlines with lead author Professor Anders Fink-Jensen to ask what the study showed, and what its implications are for the future of addiction medicine. Click here to read the full article:  https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00305-3/fulltext

Episode metadata supplied by the publisher feed · Published May 2, 2026

Embed this episode

NOW PLAYING

Can semaglutide be used to treat alcohol use disorder?

0:00 31:49

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Lancet in conversation with?

This episode is 31 minutes long.

When was this The Lancet in conversation with episode published?

This episode was published on May 2, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this The Lancet in conversation with episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!